Viewing Study NCT04533594


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-25 @ 11:48 PM
Study NCT ID: NCT04533594
Status: COMPLETED
Last Update Posted: 2023-05-25
First Post: 2020-08-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Improving Self-Efficacy Through a Telenovela: Feasibility Study
Sponsor:
Organization:

Raw JSON

{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D001008', 'term': 'Anxiety Disorders'}], 'ancestors': [{'id': 'D001523', 'term': 'Mental Disorders'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'dcruzoli@jhmi.edu', 'phone': '4109558305', 'title': 'Dulce M. Cruz-Oliver, MD', 'organization': 'JOHNS HOPKINS HOSPITAL'}, 'certainAgreement': {'piSponsorEmployee': True}}, 'adverseEventsModule': {'description': 'Adverse events data was not collected.', 'eventGroups': [{'id': 'EG000', 'title': 'NOVELA', 'description': 'Hospice family caregivers will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the video (3-6 mins) over the course of 4 hospice telehealth visits.\n\nNOVELA: The family caregivers that consent to participate will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the telenovela video (one of four episodes, each 3-6 mins) over the course of 4 hospice visits (one episode per visit). All four visits will be in person using telehealth via video-conferencing. The number of visits is based on the number of videos which content is prioritized based on previous work. The interventionist will introduce the purpose and topic of the video, facilitate video viewing and then elicit clarifying questions and reinforce main message.', 'otherNumAtRisk': 0, 'deathsNumAtRisk': 0, 'otherNumAffected': 0, 'seriousNumAtRisk': 0, 'deathsNumAffected': 0, 'seriousNumAffected': 0}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Change in HFCG Anxiety Before and After NOVELA as Assessed by the Generalized Anxiety Disorder 7-item Scale', 'denoms': [{'units': 'Participants', 'counts': [{'value': '43', 'groupId': 'OG000'}]}], 'groups': [{'id': 'OG000', 'title': 'NOVELA', 'description': 'Hospice family caregivers will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the video (3-6 mins) over the course of 4 hospice telehealth visits.\n\nNOVELA: The family caregivers that consent to participate will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the telenovela video (one of four episodes, each 3-6 mins) over the course of 4 hospice visits (one episode per visit). All four visits will be in person using telehealth via video-conferencing. The number of visits is based on the number of videos which content is prioritized based on previous work. The interventionist will introduce the purpose and topic of the video, facilitate video viewing and then elicit clarifying questions and reinforce main message.'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '8.63', 'spread': '5.41', 'groupId': 'OG000'}]}]}, {'title': 'Final', 'categories': [{'measurements': [{'value': '7.67', 'spread': '4.77', 'groupId': 'OG000'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'Baseline and up to 8 weeks', 'description': 'Generalized Anxiety Disorder 7-item (GAD-7) scale. Family caregiver indicate the frequency they have been bothered by generalized anxiety. 7-items, scale 0-3, score range 0-21; higher scores reflect higher anxiety.\n\nFinal score was collected up to 8 weeks from baseline.', 'unitOfMeasure': 'score on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Only 43 participants had baseline and up to 8 weeks data. The goal was to analyze data for participants who had scores for the baseline and final assessment.'}, {'type': 'PRIMARY', 'title': 'Change in HFCG Self-efficacy Before and After NOVELA as Assessed by the Caregiver Self-Efficacy Scale', 'denoms': [{'units': 'Participants', 'counts': [{'value': '44', 'groupId': 'OG000'}]}], 'groups': [{'id': 'OG000', 'title': 'NOVELA', 'description': 'Hospice family caregivers will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the video (3-6 mins) over the course of 4 hospice telehealth visits.\n\nNOVELA: The family caregivers that consent to participate will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the telenovela video (one of four episodes, each 3-6 mins) over the course of 4 hospice visits (one episode per visit). All four visits will be in person using telehealth via video-conferencing. The number of visits is based on the number of videos which content is prioritized based on previous work. The interventionist will introduce the purpose and topic of the video, facilitate video viewing and then elicit clarifying questions and reinforce main message.'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '3.01', 'spread': '0.47', 'groupId': 'OG000'}]}]}, {'title': 'Final score', 'categories': [{'measurements': [{'value': '3.05', 'spread': '0.40', 'groupId': 'OG000'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'Baseline and up to 8 weeks', 'description': 'Caregiver Self-Efficacy Scale (CaSES) - 21-items, scale 1-4, score range 1-4; higher scores reflect higher self-efficacy.\n\nFinal score was collected up to 8 weeks from baseline.', 'unitOfMeasure': 'score on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'We had 44 participants that completed baseline and up to 8 weeks. The goal was to analyze data for participants who had scores for the baseline and final assessment.'}, {'type': 'SECONDARY', 'title': 'Change in HFCG Satisfaction During and After NOVELA as Assessed by a Single-item Satisfaction Question', 'denoms': [{'units': 'Participants', 'counts': [{'value': '35', 'groupId': 'OG000'}]}], 'groups': [{'id': 'OG000', 'title': 'NOVELA', 'description': 'Hospice family caregivers will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the video (3-6 mins) over the course of 4 hospice telehealth visits.\n\nNOVELA: The family caregivers that consent to participate will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the telenovela video (one of four episodes, each 3-6 mins) over the course of 4 hospice visits (one episode per visit). All four visits will be in person using telehealth via video-conferencing. The number of visits is based on the number of videos which content is prioritized based on previous work. The interventionist will introduce the purpose and topic of the video, facilitate video viewing and then elicit clarifying questions and reinforce main message.'}], 'classes': [{'title': 'First score', 'categories': [{'measurements': [{'value': '4.02', 'spread': '1.06', 'groupId': 'OG000'}]}]}, {'title': 'Final score', 'categories': [{'measurements': [{'value': '4.26', 'spread': '0.89', 'groupId': 'OG000'}]}]}], 'paramType': 'MEAN', 'timeFrame': '2 weeks and up to 6 weeks', 'description': 'Single-item satisfaction question related to HFCG satisfaction with intervention. Investigator developed Likert scale item scored from 1 to 5 where 1 = "Not satisfied" and 5 = "Very satisfied".\n\nFirst score was at 2 weeks and final score was up to 6 weeks from first score assessment.', 'unitOfMeasure': 'score on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'We had first and final score of 35 participants. The goal was to analyze data for participants who had scores for the first and final assessment.'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'NOVELA', 'description': 'Hospice family caregivers will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the video (3-6 mins) over the course of 4 hospice telehealth visits.\n\nNOVELA: The family caregivers that consent to participate will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the telenovela video (one of four episodes, each 3-6 mins) over the course of 4 hospice visits (one episode per visit). All four visits will be in person using telehealth via video-conferencing. The number of visits is based on the number of videos which content is prioritized based on previous work. The interventionist will introduce the purpose and topic of the video, facilitate video viewing and then elicit clarifying questions and reinforce main message.'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'comment': 'Participants who completed baseline survey', 'groupId': 'FG000', 'numSubjects': '59'}]}, {'type': 'Started Intervention', 'comment': 'N=6 participants had their loved one died before being able to start intervention', 'achievements': [{'comment': 'Participants who started intervention after completion of baseline survey', 'groupId': 'FG000', 'numSubjects': '53'}]}, {'type': 'Completed Final Survey', 'achievements': [{'comment': 'Participants who completed second survey up to 8 weeks after baseline.', 'groupId': 'FG000', 'numSubjects': '44'}]}, {'type': 'COMPLETED', 'comment': 'N=20 participants had their loved one died before being able to complete the intervention.', 'achievements': [{'comment': 'Participants that observed all 4 videos and, therefore, completed intervention', 'groupId': 'FG000', 'numSubjects': '33'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '26'}]}], 'dropWithdraws': [{'type': 'Death', 'reasons': [{'groupId': 'FG000', 'numSubjects': '26'}]}]}], 'preAssignmentDetails': '6 participants had their "loved one" died before starting intervention'}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '59', 'groupId': 'BG000'}]}], 'groups': [{'id': 'BG000', 'title': 'NOVELA', 'description': 'Hospice family caregivers will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the video (3-6 mins) over the course of 4 hospice telehealth visits.\n\nNOVELA: The family caregivers that consent to participate will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the telenovela video (one of four episodes, each 3-6 mins) over the course of 4 hospice visits (one episode per visit). All four visits will be in person using telehealth via video-conferencing. The number of visits is based on the number of videos which content is prioritized based on previous work. The interventionist will introduce the purpose and topic of the video, facilitate video viewing and then elicit clarifying questions and reinforce main message.'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'categories': [{'measurements': [{'value': '59.8', 'spread': '10.4', 'groupId': 'BG000'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '47', 'groupId': 'BG000'}]}, {'title': 'Male', 'measurements': [{'value': '12', 'groupId': 'BG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Ethnicity (NIH/OMB)', 'classes': [{'categories': [{'title': 'Hispanic or Latino', 'measurements': [{'value': '3', 'groupId': 'BG000'}]}, {'title': 'Not Hispanic or Latino', 'measurements': [{'value': '52', 'groupId': 'BG000'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '4', 'groupId': 'BG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race (NIH/OMB)', 'classes': [{'categories': [{'title': 'American Indian or Alaska Native', 'measurements': [{'value': '1', 'groupId': 'BG000'}]}, {'title': 'Asian', 'measurements': [{'value': '1', 'groupId': 'BG000'}]}, {'title': 'Native Hawaiian or Other Pacific Islander', 'measurements': [{'value': '0', 'groupId': 'BG000'}]}, {'title': 'Black or African American', 'measurements': [{'value': '15', 'groupId': 'BG000'}]}, {'title': 'White', 'measurements': [{'value': '40', 'groupId': 'BG000'}]}, {'title': 'More than one race', 'measurements': [{'value': '1', 'groupId': 'BG000'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '1', 'groupId': 'BG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Region of Enrollment', 'classes': [{'title': 'United States', 'categories': [{'measurements': [{'value': '59', 'groupId': 'BG000'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}, {'title': 'Education', 'classes': [{'categories': [{'title': 'Primary or secondary school', 'measurements': [{'value': '16', 'groupId': 'BG000'}]}, {'title': 'College, equivalent and advanced', 'measurements': [{'value': '42', 'groupId': 'BG000'}]}, {'title': 'Did not report', 'measurements': [{'value': '1', 'groupId': 'BG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'description': 'Self-reported highest education', 'unitOfMeasure': 'Participants'}, {'title': 'Marital Status', 'classes': [{'categories': [{'title': 'Married and/or have a partner', 'measurements': [{'value': '44', 'groupId': 'BG000'}]}, {'title': 'Divorced and/or separated', 'measurements': [{'value': '9', 'groupId': 'BG000'}]}, {'title': 'Widowed', 'measurements': [{'value': '1', 'groupId': 'BG000'}]}, {'title': 'Other (never married or unknown', 'measurements': [{'value': '5', 'groupId': 'BG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'description': 'Self-reported marital status', 'unitOfMeasure': 'Participants'}, {'title': 'Relationship to patient', 'classes': [{'categories': [{'title': 'Child', 'measurements': [{'value': '29', 'groupId': 'BG000'}]}, {'title': 'Parent', 'measurements': [{'value': '4', 'groupId': 'BG000'}]}, {'title': 'Spouse or Life Partner', 'measurements': [{'value': '15', 'groupId': 'BG000'}]}, {'title': 'Other(grandchild, grandparent, friend, sibling, son/daughter-in-law and nephew).', 'measurements': [{'value': '11', 'groupId': 'BG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'description': 'Self-reported participant relationship to hospice patient', 'unitOfMeasure': 'Participants'}, {'title': 'Hospice diagnosis', 'classes': [{'categories': [{'title': 'Cancer', 'measurements': [{'value': '19', 'groupId': 'BG000'}]}, {'title': 'Cardiovascular', 'measurements': [{'value': '11', 'groupId': 'BG000'}]}, {'title': 'Neurologic', 'measurements': [{'value': '14', 'groupId': 'BG000'}]}, {'title': 'Other (multi-system, infectious and renal. )', 'measurements': [{'value': '15', 'groupId': 'BG000'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'description': 'Caregiver-reported diagnosis for hospice admission', 'unitOfMeasure': 'Participants'}]}}, 'documentSection': {'largeDocumentModule': {'largeDocs': [{'date': '2021-12-23', 'size': 1267386, 'label': 'Study Protocol', 'hasIcf': False, 'hasSap': False, 'filename': 'Prot_000.pdf', 'typeAbbrev': 'Prot', 'uploadDate': '2023-03-08T23:01', 'hasProtocol': True}, {'date': '2021-12-23', 'size': 158002, 'label': 'Statistical Analysis Plan', 'hasIcf': False, 'hasSap': True, 'filename': 'SAP_001.pdf', 'typeAbbrev': 'SAP', 'uploadDate': '2023-03-08T23:02', 'hasProtocol': False}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NA', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'SUPPORTIVE_CARE', 'interventionModel': 'SINGLE_GROUP', 'interventionModelDescription': 'Single group pretest-posttest design.'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 59}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2020-10-23', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-05', 'completionDateStruct': {'date': '2023-02-28', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2023-05-02', 'studyFirstSubmitDate': '2020-08-28', 'resultsFirstSubmitDate': '2023-03-09', 'studyFirstSubmitQcDate': '2020-08-28', 'lastUpdatePostDateStruct': {'date': '2023-05-25', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2023-05-02', 'studyFirstPostDateStruct': {'date': '2020-08-31', 'type': 'ACTUAL'}, 'resultsFirstPostDateStruct': {'date': '2023-05-25', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2022-04-30', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Change in HFCG Anxiety Before and After NOVELA as Assessed by the Generalized Anxiety Disorder 7-item Scale', 'timeFrame': 'Baseline and up to 8 weeks', 'description': 'Generalized Anxiety Disorder 7-item (GAD-7) scale. Family caregiver indicate the frequency they have been bothered by generalized anxiety. 7-items, scale 0-3, score range 0-21; higher scores reflect higher anxiety.\n\nFinal score was collected up to 8 weeks from baseline.'}, {'measure': 'Change in HFCG Self-efficacy Before and After NOVELA as Assessed by the Caregiver Self-Efficacy Scale', 'timeFrame': 'Baseline and up to 8 weeks', 'description': 'Caregiver Self-Efficacy Scale (CaSES) - 21-items, scale 1-4, score range 1-4; higher scores reflect higher self-efficacy.\n\nFinal score was collected up to 8 weeks from baseline.'}], 'secondaryOutcomes': [{'measure': 'Change in HFCG Satisfaction During and After NOVELA as Assessed by a Single-item Satisfaction Question', 'timeFrame': '2 weeks and up to 6 weeks', 'description': 'Single-item satisfaction question related to HFCG satisfaction with intervention. Investigator developed Likert scale item scored from 1 to 5 where 1 = "Not satisfied" and 5 = "Very satisfied".\n\nFirst score was at 2 weeks and final score was up to 6 weeks from first score assessment.'}]}, 'oversightModule': {'oversightHasDmc': True, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['videos', 'hospice family caregivers', 'education', 'telenovelas', 'self-efficacy', 'anxiety', 'feasibility'], 'conditions': ['Healthy']}, 'referencesModule': {'references': [{'pmid': '25594360', 'type': 'BACKGROUND', 'citation': 'Crist JD, Pasvogel A, Hepworth JT, Koerner KM. The impact of a telenovela intervention on use of home health care services and Mexican American older adult and caregiver outcomes. Res Gerontol Nurs. 2015 Mar-Apr;8(2):62-76. doi: 10.3928/19404921-20150105-02. Epub 2015 Jan 16.'}, {'pmid': '26019262', 'type': 'BACKGROUND', 'citation': 'Cruz-Oliver DM, Malmstrom TK, Fernandez N, Parikh M, Garcia J, Sanchez-Reilly S. Education Intervention "Caregivers Like Me" for Latino Family Caregivers Improved Attitudes Toward Professional Assistance at End-of-life Care. Am J Hosp Palliat Care. 2016 Jul;33(6):527-36. doi: 10.1177/1049909115584315. Epub 2015 May 27.'}, {'pmid': '31690247', 'type': 'BACKGROUND', 'citation': 'Washington KT, Oliver DP, Benson JJ, Rolbiecki AJ, Jorgensen LA, Cruz-Oliver DM, Demiris G. Factors influencing engagement in an online support group for family caregivers of individuals with advanced cancer. J Psychosoc Oncol. 2020 May-Jun;38(3):235-250. doi: 10.1080/07347332.2019.1680592. Epub 2019 Nov 6.'}, {'pmid': '32638608', 'type': 'BACKGROUND', 'citation': 'Cruz-Oliver DM, Abshire M, Budhathoki C, Oliver DP, Volandes A, Smith TJ. Reflections of Hospice Staff Members About Educating Hospice Family Caregivers Through Telenovela. Am J Hosp Palliat Care. 2021 Feb;38(2):161-168. doi: 10.1177/1049909120936169. Epub 2020 Jul 8.'}, {'pmid': '40938148', 'type': 'DERIVED', 'citation': 'Cruz-Oliver DM, Blinka MD, Milner GE, Nelson KE, Bugayong M, Durkin N, Gallo JJ, Oliver DP, Abshire Saylor M. A Mixed-Methods Analysis of Response to NOVELA Among Hospice Family Caregivers. Am J Hosp Palliat Care. 2025 Sep 12:10499091251371149. doi: 10.1177/10499091251371149. Online ahead of print.'}, {'pmid': '35446674', 'type': 'DERIVED', 'citation': 'Cruz-Oliver DM, Abshire Saylor M, Nelson KE, Milner GE, Blinka MD, Durkin N, Budhathoki C, Parker-Oliver D, Smith TJ. Hospice Family Caregiver Perceptions of Benefits and Challenges of a Telenovela Educational Intervention. J Palliat Med. 2022 Jun;25(6):945-951. doi: 10.1089/jpm.2021.0628. Epub 2022 Apr 20.'}]}, 'descriptionModule': {'briefSummary': 'In the NOVELA intervention, hospice care will be enhanced with the telenovela videos for hospice family caregivers (HFCG) education during weekly hospice visits to prepare caregivers for proper use of hospice support and healthcare services', 'detailedDescription': "Telenovela is a television drama or soap opera that can be used to lead viewers to contemplate and discuss critical issues through video storytelling. Prior work showed informational telenovelas had a positive effect on Latino family caregivers' attitudes toward end-of-life (EOL) care services. The role of videos in hospice and palliative care shows significant promise, underscoring the videos as a mode of education for family caregivers that could potentially enhance caregiver's self-efficacy, decrease caregiver's anxiety, and reduce burnout. Despite the value of video education, many programs have failed to provide engaging material.\n\nBased on input from HFCG, the investigators have produced a bilingual (Spanish and English version) four chapter telenovela video series (To Care/ El privilegio de cuidar) as part of NCI funded diversity supplement study. Founded upon extensive preliminary work, To Care portrays the journey of one hospice family as the family struggle with the hospice decision, pain management, decision-making, and finally the dying process. Averaging only 4:65 minutes, each chapter addresses one of these problems, validating family experiences and identifying potential solutions. Based on this work and interviews with hospice staff the investigators have built an intervention, NOVELA, to disseminate telenovelas to family caregivers in hospice agencies. The investigators will test the feasibility of NOVELA delivery in the hospice setting and evaluate efficacy of the intervention. The overall expectation is that NOVELA will improve self-efficacy thus lowering anxiety in hospice family caregivers. This proposal has the following aims:\n\n* Specific Aim 1: To pilot test the feasibility and acceptability of integrating NOVELA with hospice care for family caregivers of hospice patients\n* Specific Aim 2: To investigate the preliminary efficacy of integrating NOVELA with hospice care for family caregivers of hospice patients"}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Identified family caregiver of patients enrolled in hospice\n* Caregivers must be over the age of 18\n* Without cognitive impairment\n* With access to wireless device and internet.\n\nExclusion Criteria:\n\n* HFCG of patients that are actively dying\n* Caregivers younger than 18 years\n* With cognitive impairment\n* Without internet access.'}, 'identificationModule': {'nctId': 'NCT04533594', 'acronym': 'NOVELA', 'briefTitle': 'Improving Self-Efficacy Through a Telenovela: Feasibility Study', 'organization': {'class': 'OTHER', 'fullName': 'Johns Hopkins University'}, 'officialTitle': 'Improving Self-efficacy Through A Telenovela Intervention for Caregivers of Patients Receiving Hospice Care: Feasibility Study', 'orgStudyIdInfo': {'id': 'IRB00256812'}, 'secondaryIdInfos': [{'id': 'U2CNR014637', 'link': 'https://reporter.nih.gov/quickSearch/U2CNR014637', 'type': 'NIH'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'NOVELA', 'description': 'Hospice family caregivers will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the video (3-6 mins) over the course of 4 hospice telehealth visits.', 'interventionNames': ['Behavioral: NOVELA']}], 'interventions': [{'name': 'NOVELA', 'type': 'BEHAVIORAL', 'description': 'The family caregivers that consent to participate will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the telenovela video (one of four episodes, each 3-6 mins) over the course of 4 hospice visits (one episode per visit). All four visits will be in person using telehealth via video-conferencing. The number of visits is based on the number of videos which content is prioritized based on previous work. The interventionist will introduce the purpose and topic of the video, facilitate video viewing and then elicit clarifying questions and reinforce main message.', 'armGroupLabels': ['NOVELA']}]}, 'contactsLocationsModule': {'locations': [{'zip': '21287', 'city': 'Baltimore', 'state': 'Maryland', 'country': 'United States', 'facility': 'Johns Hopkins Univeristy', 'geoPoint': {'lat': 39.29038, 'lon': -76.61219}}], 'overallOfficials': [{'name': 'DULCE CRUZ-OLIVER, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Johns Hopkins University'}]}, 'ipdSharingStatementModule': {'url': 'http://palliativecareresearch.org/', 'infoTypes': ['CSR'], 'timeFrame': 'One year after completion or after publication of results and data will be available for an unknown duration of time.', 'ipdSharing': 'YES', 'description': 'The de-identified data will be submitted to the Palliative Care Research Cooperative (PCRC) data repository at the end of pilot study.', 'accessCriteria': 'Investigators may request access to the de-identified PCRC Data Repositories for secondary data analysis. Each request must be submitted in writing, must identify the research question that will be addressed, and must specify the data elements that are requested. Each request must also include a data security plan and explanation of how and for how long the data will be stored and who will have access to the data. The PCRC, and when applicable the Study Principal Investigator (PI), reviews all data requests. If all requirements are adequately met, arrangements are made to transfer the data in the most efficient, secure,and affordable manner to the requesting investigator.'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Johns Hopkins University', 'class': 'OTHER'}, 'collaborators': [{'name': 'University of Colorado, Denver', 'class': 'OTHER'}, {'name': 'National Institute of Nursing Research (NINR)', 'class': 'NIH'}], 'responsibleParty': {'type': 'SPONSOR'}}}}